Document is current
Any future updates will be listed below
-
Authors
Obara, Shinju
Syroid, Noah
Ogura, Takahiro
Pace, Nathan L.
Johnson, Ken B.
Albert, Rob
Agutter, Jim
Stuart, Ami R.
Egan, Talmage D.
- License Information
-
More Information
Article History
Received: 10 September 2019
Accepted: 7 April 2020
First Online: 30 April 2020
Compliance with ethical standards
:
: Drs. Obara, Pace, Ogura, and Stuart have nothing to disclose. Mr. Syroid reports other from Applied Medical Visualizations LLC, grants from National Institutes of Health SBIR Phase II grant no. 2R44GM066615-02., during the conduct of the study; personal fees and other from Applied Medical Visualizations LLC (Medvis), outside the submitted work; In addition, Mr. Syroid has a patent US 7,693,697 with royalties paid to Applied Medical Visualizations LLC (Medvis), and a patent US 8,744,779 with royalties paid to Applied Medical Visualizations LLC (Medvis). Dr. Johnson reports grants from GE Healthcare, during the conduct of the study; other from Applied Medical Visualizations, LLC, outside the submitted work; and is an author on several published manuscripts that describe the models used in the drug display presented in this manuscript. Mr. Albert reports In addition, Mr. Albert has a patent US Patent 7693697 - Anesthesia Drug Monitor - Method and Apparatus for Monitoring Anesthesia Drug Dosages, Concentrations, and effects using n-dimensional representations of critical functions. issued. Mr. Agutter reports other from Applied Medical Visualizations LLC, grants from National Institutes of Health SBIR Phase II grant no. 2R44GM066615-02., during the conduct of the study; personal fees and other from Applied Medical Visualizations LLC (Medvis), outside the submitted work; In addition, Mr. Agutter has a patent US 7,693,697 with royalties paid to Applied Medical Visualizations LLC (Medvis), and a patent US 8,744,779 with royalties paid to Applied Medical Visualizations LLC (Medvis). Dr. Egan reports other from Applied Medical Visualizations, during the conduct of the study; other from Paion, outside the submitted work; In addition, Dr. Egan has a patent US8744779B2.
: This study was approved by the Utah University Institutional Review Board (IRB#00010599) and was registered prior to patient enrollment at clinicaltrials.gov (NCT00714012). All procedures in this study were in accordance with the ethical standards of the University of Utah Institutional Review Board and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Written informed consent was obtained from all the subjects.
